Steward Partners Investment Advisory, LLC Sangamo Therapeutics, Inc Transaction History

Steward Partners Investment Advisory, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$2.77 - $5.07 $4,155 - $7,605	-1,500 Reduced 60.0%	1,000 $3,000
Q2 2022 Aug 04, 2022	SELL	$3.28 - $6.21 $2,368 - $4,483	-722 Reduced 22.41%	2,500 $10,000
Q4 2021 Feb 08, 2022	SELL	$7.29 - $10.97 $2,478 - $3,729	-340 Reduced 9.55%	3,222 $24,000
Q4 2020 Feb 11, 2021	SELL	$9.23 - $18.18 $4,615 - $9,090	-500 Reduced 12.31%	3,562 $56,000
Q2 2020 Aug 06, 2020	SELL	$6.21 - $11.83 $621 - $1,183	-100 Reduced 2.4%	4,062 $36,000
Q1 2020 Apr 29, 2020	SELL	$5.05 - $8.85 $2,065 - $3,619	-409 Reduced 8.95%	4,162 $26,000
Q4 2019 Jan 17, 2020	SELL	$8.03 - $11.7 $730 - $1,064	-91 Reduced 1.95%	4,571 $38,000
Q2 2019 Jul 25, 2019	BUY	$8.75 - $13.03 $40,792 - $60,745	4,662 New	4,662 $50,000
Q4 2018 Jan 15, 2019	SELL	$9.51 - $16.6 $45,762 - $79,879	-4,812 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$13.05 - $19.05 $9,787 - $14,287	750 Added 18.46%	4,812 $82,000
Q2 2018 Jul 20, 2018	SELL	$13.9 - $19.8 $4,517 - $6,435	-325 Reduced 7.41%	4,062 $58,000
Q3 2017 Nov 22, 2017	SELL	$8.4 - $15.0 $428 - $765	-51 Reduced 1.15%	4,387 $65,000
Q4 2016 Nov 22, 2017	BUY	N/A	4,438	4,438 $13,000

111

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.